Association between p53 codon 72 polymorphism and sarcoma risk among Caucasians

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The tumor suppressor gene p53 plays a crucial role in preventing cancer.
• The p53 codon 72 polymorphism (Pro72Arg) is a common genetic variation with potential implications for cancer risk.
• Previous studies on the association between p53 codon 72 polymorphism and sarcoma risk have yielded inconsistent findings.

Purpose of the Study:

• To conduct a comprehensive meta-analysis to clarify the association between the p53 codon 72 polymorphism and sarcoma risk.
• To provide a more precise estimation of this genetic association specifically among Caucasian populations.
• To investigate potential influences of ethnicity, control source, and sarcoma type on this association.

Main Methods:

• A systematic literature search was performed across major databases (PubMed, EMBASE, Web of Science, CNKI).
• Case-control studies investigating the p53 codon 72 polymorphism and sarcoma risk were included.
• A meta-analysis was conducted using STATA 12.0, calculating odds ratios (ORs) and 95% confidence intervals (CIs) to assess risk.

Main Results:

• The meta-analysis revealed no statistically significant evidence of increased sarcoma risk associated with the p53 codon 72 polymorphism across various genetic models (e.g., Arg/Arg vs. Pro/Pro, allele Arg vs. allele Pro).
• Specific ORs and 95% CIs consistently indicated a lack of association, with heterogeneity tests showing no significant variations (P(heterogeneity) values were high).
• Subgroup analyses stratified by ethnicity, control source, and sarcoma type also failed to identify any significant links.

Conclusions:

• The p53 codon 72 polymorphism does not appear to be a significant risk factor for sarcoma development in Caucasian individuals.
• This meta-analysis suggests that the investigated genetic variation may not play a substantial role in the etiology of sarcoma.
• Further research may be warranted to explore other genetic or environmental factors contributing to sarcoma risk.